“showed a trend”

During follow-up (median time 6 month) FBG was available for 321 out of the 453 (70.9%) surviving patients and showed a trend to a marginal increase [from 97 (87–116) to 100 (92–114) mg/dL; p = 0.071].

Diabetes mellitus showed a trend toward increased risk (OR = 4.80, 95% CI: 0.90–26.60, p = 0.071), though this did not reach statistical significance.

SGM cancer survivors with cardiovascular disease showed a trend ( p = 0.071) toward lower odds of living in a state with protective policies (AOR: 0.89; 95% CI: 0.78–1.01).

The attention scores showed a trend towards improvement after dapagliflozin treatment ( p = 0.071); the difference did not reach statistical significance.

In patients with low TIL levels, the stromal CD8 + IC/CD4 + FOXP3 + IC ratio showed a trend toward being higher in the pCR group (5.9 ± 0.8 vs. 3.2 ± 1.9, p = 0.071).

In our study, patients with Exon20ins-L mutations showed a trend of longer TTF towards second than first and third generation EGFR TKIs (5.6 months vs. 1.5 months vs. 2.6 months, p = 0.071).

The experience of financial problems during the pandemic was significantly associated with a 0.29-point reduction of perceived family happiness after controlling for other factors (Model 1: Beta = −0.29, bootstrap SE = 0.12, P = 0.014), whereas the experience of close persons died of COVID-19 infection only showed a trend of association without reaching the threshold of statistical significance (Model 1: Beta = −0.29, bootstrap SE = 0.16, P = 0.071).

An analysis of OS showed a trend toward statistical significance with decreased TTAC (HR 1.004 [0.9997–1.0084]; p = 0.071).

The correlation between age and brain glucose metabolism In the control group, Spearman’s correlation coefficient showed a trend toward association between age and brain glucose metabolism at the left prefrontal medial ( p = 0.071, r = 0.667) and right temporal lateral ( p = 0.072, r = 0.665).

Older participants showed a trend for lower memory scores than younger ones ( T (53) = 1.49, P = 0.071); thus, despite the significant main effect of age in the ANOVA, the effect in the post-hoc T -test was only at trend level (one-sided two-sample T -test; see Fig. 2 ).

However, cluster sizes in the networks from the 5–7 RTI group showed a trend towards less increase over time compared to clusters from networks from the 0–2 RTI group (negative binomial GLM: 5–7 RTI group estimate = − 0.3, p = 0.071), which coincided with a higher number of clusters retained in the 5–7 RTI networks.

The Parker mobility score showed a trend ( p = 0.071 ) of being lower in patients with infections.

Meanwhile, OS also showed a trend toward worse outcomes in the EBER-negative group, albeit without significance (82.0% [95% CI, 70.3%−95.6%] vs. 89.2% [95% CI, 83.7%−95.1%], P = 0.071, Fig. 3 D).

Results With data available from three studies ( N = 12 647), the addition of CDK4/6is to adjuvant ET showed a trend for a benefit in terms of invasive disease-free survival (IDFS; HR 0.85, 95% CI 0.71-1.01; P = 0.071).

And iMFV/cMFV ≥1.12 showed a trend for independently predicting END VCE and sICH (OR: 4.09, 95% CI: 0.89–18.94, P = 0.071).

Patients <56 years old showed a trend toward better OS ( P = 0.071).

Similarly, postprandial PYY secretion also showed a trend for diminished afternoon levels only in IFG/IGT subjects ( Fig. 4A ) (p = 0.071 for difference of Δ between NGT and IFG/IGT).

Although C-peptide levels showed a trend towards reduction (p = 0.071), fasting glucose levels, lipid profiles, and estimated glomerular filtration rates remained unchanged.

A sensitivity analysis including only ischemic strokes showed a trend for the association between PAD and stroke (HR 1.5, P =0.071).

Concurrent steroid use was associated with fewer immune-related adverse events (0% vs 30%, P =0.052) but showed a trend toward shorter PFS (HR=2.30, P =0.071).

Clinical parameters such as the Charlson Comorbidity Index showed a trend toward higher values in the slow gait speed group (4.0 [3.0–5.0] vs. 2.0 [0.0–4.0], p = 0.071) but did not reach statistical significance.

For life evaluation (the evaluative component of SWB), the results only showed a trend to significant differences (F(3,332) = 2.37, p = .071).

Males showed a trend toward larger posterior space values (coef. = 0.39; 95% CI: -0.03, 0.82; p = 0.071), although the difference was not statistically significant.

In this case, a trend toward significance suggested the inclusion of time ( χ 2 (4) = 8.4, p = 0.077), where the evaluation at T2 showed a trend toward improvement compared to the baseline ( p = 0.071), probably as an effect of the task repetition since the assessment was repeated in a shorter time (every month) up to T2 and then with longer time intervals (see Figure 3 ).

Cox regression analysis Patients with AF1q positive RC showed a trend towards a higher risk for disease recurrence ( p = 0.071), but no impact on disease-specific death.